Loading clinical trials...
Loading clinical trials...
The purpose of the study is to evaluate the safety and effectiveness of the UroLift(R) System when used in subjects with symptomatic benign hyperplasia (BPH). Primary effectiveness will be achieved by...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
NeoTract, Inc.
NCT07650968 · Acute Urinary Retention, Benign Prostatic Hyperplasia
NCT07643220 · Moderate-to-severe Benign Prostatic Hyperplasia (BPH)
NCT07629479 · Benign Prostatic Hyperplasia, Lower Urinary Tract Symptoms, and more
NCT05574244 · Benign Prostatic Hyperplasia
NCT06668142 · Benign Prostatic Hyperplasia
Genesis Research LLC
San Diego, California
Shahram S. Gholami MD - A Professional Corp.
San Jose, California
Urology Associates of Denver
Englewood, Colorado
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions